Skip to main content

Table 2 Anthropometric, clinical, and biochemical parameters of the study population by MetS

From: Association of rs9939609-FTO with metabolic syndrome components among women from Mayan communities of Chiapas, Mexico

Variables With MetS (n) Median (p25–p75) or % (95% CI) Without MetS (n) Median (p25–p75) or % (95% CI) Total Median or % (95% CI)
Waist circumference 175 95 (88–102) 116 90 (84–84.5) 291 93 (92–95)
  < 80 cm 2 1.1 (a) 20 17.2 (11.2–24.9) 22 7.6 (4.9–11)
  ≥ 80 cm 173 98.9 (96.4–99.8) 96 82.8 (75.1–88.8) 269 92.4 (89.0–95.1)
BMI 175 30.7 (28.1–33.9) 116 28.1 (25.2–30.1) 291 29.7 (26.8.0–32.3)
  < 25 kg/m2 7 4.0 (1.8–7.7) 27 23.3 (16.3–31.6) 34 11.7 (8.4–15.7)
  ≥ 25 kg/m2 168 96.0 (92.3–98.2) 89 76.7 (68.4–83.7) 257 88.3 (84.3–91.6)
Blood pressure
SBP 175 124 (115–139) 116 115 (108–122) 291 120 (111–132)
DBP 175 76 (68–83) 116 70.5 (66–75) 291 74 (67–80)
SBP < 130/DBP < 85 mm Hg 90 51.4 (44.1–58.8) 108 93.1 (87.4–96.7) 198 68.0 (62.5–73.2)
SBP ≥ 130/DBP ≥ 85 mm Hg 85 48.6 (41.2–55.9) 8 6.9 (3.3–12.6) 93 32.0 (26.8–37.5)
Triglycerides 175 201 (166–283) 116 123 (96–149) 291 174 (126–228)
  < 150 mg/dL 22 12.6 (8.3–18.1) 90 77.6 (69.4–84.4) 112 38.5 (33.0–44.2)
  ≥ 150 mg/dL 153 87.4 (81.9–91.7) 26 22.4 (15.6–30.6) 179 61.5 (55.8–67.0)
HDL-c 175 42.5 (37.9–48.1) 116 50.1 (40.4–55.1) 291 44.3 (38.9–51.2)
  ≥ 50 mg/dL 26 14.9 (10.2–20.7) 60 51.7 (42.7–60.7) 86 29.6 (24.5–35.0)
  < 50 mg/dL 149 85.1 (79.3–89.8) 56 48.3 (39.3–57.3) 205 70.4 (65.0–75.5)
Glucose 175 92 (83.5–104) 116 83 (76–89.5) 291 88.0 (80.5–97.5)
  < 100 mg/dL 118 67.4 (60.2–74.0) 110 94.8 (89.7–97.8) 228 78.4 (73.4–82.8)
  ≥ 100 mg/dL 57 32.6 (26.0–39.8) 6 5.2 (2.2–10.3) 63 21.6 (17.2–26.6)
  1. aNot available